|
Profit & Loss for MIG pursuant to Moore Discl Statement
|
3
|
Mosaic ImmunoEngineering Inc.
|
Sep 09, 2014 06:42PM
|
|
Re: MIG concern Caney
|
3
|
Mosaic ImmunoEngineering Inc.
|
Sep 08, 2014 07:06PM
|
|
HUB leaders if you support Moore's plan
|
11
|
Mosaic ImmunoEngineering Inc.
|
Sep 08, 2014 12:12PM
|
|
Re: Shareholder effort to support Moore's plan...Laurie ..Ron thanks eom
|
1
|
Mosaic ImmunoEngineering Inc.
|
Sep 05, 2014 04:32PM
|
|
Shareholder effort to support Moore's plan
|
15
|
Mosaic ImmunoEngineering Inc.
|
Sep 05, 2014 03:07PM
|
|
I like Moore's plan
|
17
|
Mosaic ImmunoEngineering Inc.
|
Sep 04, 2014 08:03PM
|
|
Re: TPL BK Pacers-BaN
|
10
|
Mosaic ImmunoEngineering Inc.
|
Sep 04, 2014 07:57PM
|
|
The Moore Plan (MMP Plan)
|
16
|
Mosaic ImmunoEngineering Inc.
|
Sep 01, 2014 01:27PM
|
|
From Moore's disclosure Statement
|
15
|
Mosaic ImmunoEngineering Inc.
|
Sep 01, 2014 12:56PM
|
|
Plan to be presented Sept. 17, 2014
|
11
|
Mosaic ImmunoEngineering Inc.
|
Aug 19, 2014 04:45PM
|
|
PDS third member by arbitration
|
3
|
Mosaic ImmunoEngineering Inc.
|
Aug 19, 2014 04:40PM
|
|
Re: Just in- ADS Tks eom
|
2
|
Mosaic ImmunoEngineering Inc.
|
Aug 19, 2014 04:25PM
|
|
Regarding today's motion
|
2
|
Mosaic ImmunoEngineering Inc.
|
Aug 19, 2014 04:24PM
|
|
Re: PDS third member by arbitration-bank
|
1
|
Mosaic ImmunoEngineering Inc.
|
Aug 19, 2014 04:14PM
|
|
PDS third member by arbitration
|
2
|
Mosaic ImmunoEngineering Inc.
|
Aug 19, 2014 02:44PM
|
|
Re: joint BK Plan & Disclosure statement were never filed...Laurie, Ron
|
3
|
Mosaic ImmunoEngineering Inc.
|
Aug 19, 2014 10:57AM
|
|
Ron...The joint BK Plan & Disclosure statement were never filed
|
6
|
Mosaic ImmunoEngineering Inc.
|
Aug 18, 2014 07:29PM
|
|
Terrorist response training at major mall tonight
|
2
|
Mosaic ImmunoEngineering Inc.
|
Aug 17, 2014 11:53AM
|
|
Lifecycle chart for MMP
|
2
|
Mosaic ImmunoEngineering Inc.
|
Aug 15, 2014 04:03PM
|
|
Fourth Motion to approve use of Cash Collateral
|
7
|
Mosaic ImmunoEngineering Inc.
|
Aug 15, 2014 11:26AM
|
